1
|
Mouillé M, Rio M, Breton S, Piketty ML, Afenjar A, Amiel J, Capri Y, Goldenberg A, Francannet C, Michot C, Mignot C, Perrin L, Quelin C, Van Gils J, Barcia G, Pingault V, Maruani G, Koumakis E, Cormier-Daire V. SATB2-associated syndrome: characterization of skeletal features and of bone fragility in a prospective cohort of 19 patients. Orphanet J Rare Dis 2022; 17:100. [PMID: 35241104 PMCID: PMC8895909 DOI: 10.1186/s13023-022-02229-5] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2021] [Accepted: 02/06/2022] [Indexed: 11/10/2022] Open
Abstract
Background Individuals with pathogenic variants in SATB2 display intellectual disability, speech and behavioral disorders, dental abnormalities and often features of Pierre Robin sequence. SATB2 encodes a transcription factor thought to play a role in bone remodeling. The primary aim of our study was to systematically review the skeletal manifestations of SATB2-associated syndrome. For this purpose, we performed a non-interventional, multicenter cohort study, from 2017 to 2018. We included 19 patients, 9 females and 10 males ranging in age from 2 to 19 years-old. The following data were collected prospectively for each patient: clinical data, bone markers and calcium and phosphate metabolism parameters, skeletal X-rays and bone mineral density. Results Digitiform impressions were present in 8/14 patients (57%). Vertebral compression fractures affected 6/17 patients (35%). Skeletal demineralization (16/17, 94%) and cortical thinning of vertebrae (15/17) were the most frequent radiological features at the spine. Long bones were generally demineralized (18/19). The distal phalanges were short, thick and abnormally shaped. C-telopeptide (CTX) and Alkaline phosphatase levels were in the upper normal values and osteocalcin and serum procollagen type 1 amino-terminal propeptide (P1NP) were both increased. Vitamin D insufficiency was frequent (66.7%). Conclusion We conclude that SATB2 pathogenic variants are responsible for skeletal demineralization and osteoporosis. We found increased levels of bone formation markers, supporting the key role of SATB2 in osteoblast differentiation. These results support the need for bone evaluation in children and adult patients with SATB2-associated syndrome (SAS). Supplementary Information The online version contains supplementary material available at 10.1186/s13023-022-02229-5.
Collapse
Affiliation(s)
- M Mouillé
- Clinical Genetics, Necker Enfants Malades Hospital, APHP, 149 rue de Sevres, Paris, 75015, France.,Department of Neonatal Medicine, Cochin-Port Royal Hospital, APHP, Paris, France
| | - M Rio
- Clinical Genetics, Necker Enfants Malades Hospital, APHP, 149 rue de Sevres, Paris, 75015, France
| | - S Breton
- Department of Pediatric Radiology, Necker Enfants Malades Hospital, APHP, Paris, France
| | - M L Piketty
- Functional Exploration Laboratory, Necker Enfants Malades Hospital, APHP, Paris, France
| | - A Afenjar
- Sorbonne University, Reference Center for Intellectual Disabilities, Department of Genetics and Medical Embryology, Armand-Trousseau Hospital, APHP, Paris, France
| | - J Amiel
- Clinical Genetics, Necker Enfants Malades Hospital, APHP, 149 rue de Sevres, Paris, 75015, France
| | - Y Capri
- Clinical Genetics Functional Unit, Robert Debré Hospital, APHP, Paris, France
| | | | - C Francannet
- Clinical Genetics, Clermont-Ferrand CHU, Clermont-Ferrand, France
| | - C Michot
- Clinical Genetics, Necker Enfants Malades Hospital, APHP, 149 rue de Sevres, Paris, 75015, France.,Paris Cité University, Reference Center for Constitutional Bone Diseases, INSERM UMR1163, Imagine Institute, Paris, France
| | - C Mignot
- Sorbonne University, Reference Center for Intellectual Disabilities, Department of Genetics and Medical Embryology, Armand-Trousseau Hospital, APHP, Paris, France.,Clinical Genetics, La Pitié Salpétrière Hospital, APHP, Paris, France
| | - L Perrin
- Clinical Genetics Functional Unit, Robert Debré Hospital, APHP, Paris, France
| | - C Quelin
- Clinical Genetics, Hospital Sud, Rennes, France
| | - J Van Gils
- Clinical Genetics, Hospital Pellegrin, Bordeaux, France
| | - G Barcia
- Molecular Genetics, Necker Enfants Malades Hospital, APHP, Paris, France
| | - V Pingault
- Molecular Genetics, Necker Enfants Malades Hospital, APHP, Paris, France
| | - G Maruani
- Department of Physiology, Hôpital Necker Enfants Malades and Hôpital Européen Georges Pompidou, AP-HP, Paris, France
| | - E Koumakis
- Paris Cité University, Reference Center for Constitutional Bone Diseases, INSERM UMR1163, Imagine Institute, Paris, France.,Reference Center for Skeletal Dysplasia, Cochin Hospital, APHP, Paris, France
| | - V Cormier-Daire
- Clinical Genetics, Necker Enfants Malades Hospital, APHP, 149 rue de Sevres, Paris, 75015, France. .,Paris Cité University, Reference Center for Constitutional Bone Diseases, INSERM UMR1163, Imagine Institute, Paris, France.
| |
Collapse
|
2
|
Sorlin A, Carmignac V, Amiel J, Boccara O, Fraitag S, Maruani A, Theiler M, Weibel L, Duffourd Y, Philippe C, Thauvin-Robinet C, Faivre L, Rivière JB, Vabres P, Kuentz P. Expanding the clinical spectrum of mosaic BRAF skin phenotypes. J Eur Acad Dermatol Venereol 2021; 35:e690-e693. [PMID: 34051131 DOI: 10.1111/jdv.17413] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2021] [Accepted: 05/19/2021] [Indexed: 11/28/2022]
Affiliation(s)
- A Sorlin
- Centre de Génétique et Centre de référence « Anomalies du Développement et Syndromes Malformatifs », Hôpital d'Enfants, Centre Hospitalier Universitaire de Dijon, Dijon, France.,UMR-Inserm 1231 GAD, Génétique des Anomalies du développement, Université de Bourgogne Franche-Comté, Dijon, France
| | - V Carmignac
- UMR-Inserm 1231 GAD, Génétique des Anomalies du développement, Université de Bourgogne Franche-Comté, Dijon, France
| | - J Amiel
- Service de Génétique Médicale, Hôpital Necker-Enfants Malades, APHP, Paris, France
| | - O Boccara
- Department of Dermatology and Reference Center for Genodermatoses and Rare Skin Diseases (MAGEC), Université Paris, Paris-Centre, Institut Imagine, Hôpital Universitaire Necker-Enfants Malades, APHP, Paris, France
| | - S Fraitag
- Service d'Anatomie et de Cytologie Pathologiques, APHP, Hôpital Necker-Enfants Malades, Paris, France
| | - A Maruani
- Service de Dermatologie, Centre de Référence des Maladies Rares - MAGEC, Centre Hospitalier Universitaire de Tours, Université de Tours, SPHERE-INSERM 1246, Tours, France
| | - M Theiler
- Pediatric Skin Center, Department of Dermatology, University Children's Hospital Zurich, Zurich, Switzerland
| | - L Weibel
- Pediatric Skin Center, Department of Dermatology, University Children's Hospital Zurich, Zurich, Switzerland
| | - Y Duffourd
- UMR-Inserm 1231 GAD, Génétique des Anomalies du développement, Université de Bourgogne Franche-Comté, Dijon, France.,Fédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement (FHU TRANSLAD), Centre Hospitalier Universitaire de Dijon et Université de Bourgogne Franche-Comté, Dijon, France
| | - C Philippe
- UMR-Inserm 1231 GAD, Génétique des Anomalies du développement, Université de Bourgogne Franche-Comté, Dijon, France.,Fédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement (FHU TRANSLAD), Centre Hospitalier Universitaire de Dijon et Université de Bourgogne Franche-Comté, Dijon, France.,UF Innovation en diagnostic génomique des maladies rares, CHU de Dijon Bourgogne, Dijon, France
| | - C Thauvin-Robinet
- Centre de Génétique et Centre de référence « Anomalies du Développement et Syndromes Malformatifs », Hôpital d'Enfants, Centre Hospitalier Universitaire de Dijon, Dijon, France.,UMR-Inserm 1231 GAD, Génétique des Anomalies du développement, Université de Bourgogne Franche-Comté, Dijon, France.,Fédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement (FHU TRANSLAD), Centre Hospitalier Universitaire de Dijon et Université de Bourgogne Franche-Comté, Dijon, France
| | - L Faivre
- Centre de Génétique et Centre de référence « Anomalies du Développement et Syndromes Malformatifs », Hôpital d'Enfants, Centre Hospitalier Universitaire de Dijon, Dijon, France.,UMR-Inserm 1231 GAD, Génétique des Anomalies du développement, Université de Bourgogne Franche-Comté, Dijon, France.,Fédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement (FHU TRANSLAD), Centre Hospitalier Universitaire de Dijon et Université de Bourgogne Franche-Comté, Dijon, France
| | - J-B Rivière
- UMR-Inserm 1231 GAD, Génétique des Anomalies du développement, Université de Bourgogne Franche-Comté, Dijon, France.,Fédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement (FHU TRANSLAD), Centre Hospitalier Universitaire de Dijon et Université de Bourgogne Franche-Comté, Dijon, France.,UF Innovation en diagnostic génomique des maladies rares, CHU de Dijon Bourgogne, Dijon, France
| | - P Vabres
- UMR-Inserm 1231 GAD, Génétique des Anomalies du développement, Université de Bourgogne Franche-Comté, Dijon, France.,Fédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement (FHU TRANSLAD), Centre Hospitalier Universitaire de Dijon et Université de Bourgogne Franche-Comté, Dijon, France.,Service de Dermatologie, Centre Hospitalier Universitaire de Dijon, Dijon, France
| | - P Kuentz
- UMR-Inserm 1231 GAD, Génétique des Anomalies du développement, Université de Bourgogne Franche-Comté, Dijon, France.,Fédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement (FHU TRANSLAD), Centre Hospitalier Universitaire de Dijon et Université de Bourgogne Franche-Comté, Dijon, France.,Oncobiologie Génétique Bioinformatique, PCBio, Centre Hospitalier Universitaire de Besançon, Besançon, France
| |
Collapse
|
3
|
Grilo SA, Catallozzi M, Desai U, Sein AS, Quinteros-Baumgart C, Timmins G, Edelman D, Amiel J. Columbia COVID-19 Student Service Corps: Harnessing Student Skills and Galvanizing the Power of Service Learning. FASEB Bioadv 2020; 3:166-174. [PMID: 33363269 PMCID: PMC7753454 DOI: 10.1096/fba.2020-00105] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2020] [Revised: 11/11/2020] [Accepted: 11/12/2020] [Indexed: 11/11/2022] Open
Abstract
The COVID‐19 pandemic in New York City led to the forced rapid transformation of the medical school curriculum as well as increased critical needs to the health system. In response, a group of faculty and student leaders at CUIMC developed the COVID‐19 Student Service Corps (Columbia CSSC). The CSSC is an interprofessional service‐learning organization that galvanizes the skills and expertise of faculty and students from over 12 schools and programs in the response to the COVID‐19 pandemic, and is agile enough to shift and respond to future public health and medical emergencies. Since March 2020, over 30 projects have been developed and implemented supporting needs identified by the health system, providers, faculty, staff, and students as well as the larger community. The development of the CSSC also provided critical virtual educational opportunities in the form of service learning for students who were unable to have any in‐person instruction. The CSSC model has been shared nationally and nine additional chapters have started at academic institutions across the country.
Collapse
Affiliation(s)
- S A Grilo
- Columbia University Mailman School of Public Health Heilbrunn Department of Population and Family Health 60 Haven Avenue, B-2-221 New York NY 10032 USA
| | - M Catallozzi
- Columbia University Medical Center Department of Pediatrics Vagelos College of Physicians and Surgeons Heilbrunn Department of Population and Family Health 650 W 168th Street, PH 520 New York NY 10032 USA
| | - U Desai
- Columbia University Medical Center Department of Family Medicine Vagelos College of Physicians and Surgeons 650 W 168th Street New York NY 10032 USA
| | - A Swan Sein
- Center for Education Research and Evaluation Columbia University Medical Center 100 Haven Avenue, Tower 3 Room L3A-01 New York NY 10032 USA
| | - C Quinteros-Baumgart
- Columbia University Vagelos College of Physicians and Surgeons M.D. Candidate Class of 2022
| | - G Timmins
- Columbia University Mailman School of Public Health MPH Candidate Class of 2021
| | - D Edelman
- Primary Care/Social Internal medicine Resident at Montefiore Health System
| | - J Amiel
- Interim Co-Vice Dean for Education and Senior Associate Dean for Curricular Affairs Columbia University Vagelos College of Physicians and Surgeons
| |
Collapse
|
4
|
Haider R, Tibi B, Ahallal Y, Colomb F, Chevallier D, Amiel J, Durand M. Impact du volume prostatique traité après photovaporisation prostatique au laser GreenLight XPS 180 W. Prog Urol 2020. [DOI: 10.1016/j.purol.2020.07.218] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
5
|
Vignot L, Ambrosetti D, Dupré F, Dimauro I, Annie-claude P, Quintens H, Durand M, Amiel J, Michiels J, Pedeutour F. Phénomène de tétraploidisation dans les carcinomes à cellules rénales chromophores : difficultés de caractérisation et conséquences. Prog Urol 2019. [DOI: 10.1016/j.purol.2019.08.057] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
6
|
Haider R, Fallot J, Tibi B, Ahallal Y, Colomb F, Chevallier D, Amiel J, Durand M. Vapo-énucléation ou photovaporisation prostatique au laser Greenlight XPS 180 W pour prostate < 100 mL en ambulatoire. Prog Urol 2019. [DOI: 10.1016/j.purol.2019.08.163] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
7
|
Vignot L, Ahallal Y, Amiel J, Chevallier D, Durand M. Néphrectomie laparoscopique robot-assistée chez un donneur vivant : aspects techniques et avantages de l’extraction vaginale. Prog Urol 2019. [DOI: 10.1016/j.purol.2019.08.027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
8
|
Durand M, Bessede T, Treacy P, Bentellis I, Amiel J, Corcuera-solano I, Taouli B, Rastinehad A, Ying Tang C, Wang V, Reddy B, Raffaelli C, Fromont G, Puech P, Haines K, Tewari A, Villers A. Imagerie expérimentale ex vivo de haute résolution à 7 tesla du cancer localisé de la prostate. Prog Urol 2019. [DOI: 10.1016/j.purol.2019.08.083] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
9
|
Bentellis I, Tibi B, Ahallal Y, Mbeutcha A, Mendel L, Haider R, Regnier P, Treacy P, Bodokh Y, Amiel J, Chevallier D, Durand M. Analyse d’un modèle de circuit court post-urgence avec une régulation précoce urologique. Prog Urol 2019. [DOI: 10.1016/j.purol.2019.08.115] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
10
|
Morice A, Galliani E, Amiel J, Rachwalski M, Neiva C, Thauvin-Robinet C, Vazquez MP, Picard A, Kadlub N. Diagnostic criteria in Pai syndrome: results of a case series and a literature review. Int J Oral Maxillofac Surg 2019; 48:283-290. [DOI: 10.1016/j.ijom.2018.08.010] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2018] [Revised: 06/01/2018] [Accepted: 08/20/2018] [Indexed: 10/28/2022]
|
11
|
Moreau De Bellaing A, Guimier A, Bajolle F, Turner C, Grove M, Dunn K, Katta G, Crozier I, Kidd A, Mayr J, Rotig A, Di Rago J, Delahodde A, Lyonnet S, Doudney K, Kennedy H, Amiel J, Gordon C, Bonnet D. PPA2 gene is involved in neonatal fatal acute dilated cardiomyopathy. Archives of Cardiovascular Diseases Supplements 2019. [DOI: 10.1016/j.acvdsp.2018.10.296] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
12
|
Tibi B, Treacy P, Bodokh Y, Haider R, Vignot L, Regnier P, Fallot J, Ahallal Y, Amiel J, Chevallier D, Durand M. Faisabilité de la promontofixation laparoscopique avec ou sans assistance robotique en ambulatoire. Prog Urol 2018. [DOI: 10.1016/j.purol.2018.07.063] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
13
|
Rambaud C, Gonfrier S, Arlaud C, Fallot J, Guerin O, Amiel J, Chevallier D, Durand M. Rétention urinaire chronique : suivi à 6 mois des patients ayant bénéficié d’une alternative au sondage vésicale définitif, à l’issu d’une réunion multidisciplinaire uro-gériatrique. Prog Urol 2017. [DOI: 10.1016/j.purol.2017.07.194] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
14
|
Roustan F, Bentellis I, Lareyre F, Raffort J, Sedat J, Elixène J, Amiel J, Chevallier D, Durand M. Évaluation de 15 ans de traitement endovasculaire de sténoses artérielles péri-anastomotique des greffes rénales : une étude rétrospective, monocentrique. Prog Urol 2017. [DOI: 10.1016/j.purol.2017.07.186] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
15
|
Bentellis I, Prader R, Tibi B, Fallot J, Haider R, Regnier P, Treacy P, Bodokh Y, Durand M, Amiel J, Chevallier D. Une filière de circuit court post-service d’accueil des urgences comme alternative à l’hospitalisation conventionnelle : évaluation rétrospective sur 16 mois. Prog Urol 2017. [DOI: 10.1016/j.purol.2017.07.193] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
16
|
Gordon C, Tessier A, Demir Z, Goldenberg A, Oufadem M, Voisin N, Pingault V, Bienvenu T, Lyonnet S, de Pontual L, Amiel J. The association of severe encephalopathy and question mark ear is highly suggestive of loss of MEF2C
function. Clin Genet 2017; 93:356-359. [DOI: 10.1111/cge.13046] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2017] [Revised: 04/24/2017] [Accepted: 04/25/2017] [Indexed: 12/14/2022]
Affiliation(s)
- C.T. Gordon
- Laboratory of Embryology and Genetics of Congenital Malformations, Institut National de la Santé et de la Recherche Médicale (INSERM) UMR 1163; Institut Imagine; Paris France
- Paris Descartes-Sorbonne Paris Cité University; Institut Imagine; Paris France
| | - A. Tessier
- Laboratory of Embryology and Genetics of Congenital Malformations, Institut National de la Santé et de la Recherche Médicale (INSERM) UMR 1163; Institut Imagine; Paris France
- Paris Descartes-Sorbonne Paris Cité University; Institut Imagine; Paris France
| | - Z. Demir
- Département de Génétique, Hôpital Necker-Enfants Malades; Assistance Publique Hôpitaux de Paris (AP-HP); Paris France
| | - A. Goldenberg
- Service de Génétique, CHU de Rouen; Centre Normand de Génomique Médicale et Médecine Personnalisée; Rouen France
| | - M. Oufadem
- Laboratory of Embryology and Genetics of Congenital Malformations, Institut National de la Santé et de la Recherche Médicale (INSERM) UMR 1163; Institut Imagine; Paris France
- Paris Descartes-Sorbonne Paris Cité University; Institut Imagine; Paris France
| | - N. Voisin
- Laboratory of Embryology and Genetics of Congenital Malformations, Institut National de la Santé et de la Recherche Médicale (INSERM) UMR 1163; Institut Imagine; Paris France
- Paris Descartes-Sorbonne Paris Cité University; Institut Imagine; Paris France
| | - V. Pingault
- Laboratory of Embryology and Genetics of Congenital Malformations, Institut National de la Santé et de la Recherche Médicale (INSERM) UMR 1163; Institut Imagine; Paris France
- Paris Descartes-Sorbonne Paris Cité University; Institut Imagine; Paris France
- Département de Génétique, Hôpital Necker-Enfants Malades; Assistance Publique Hôpitaux de Paris (AP-HP); Paris France
| | - T. Bienvenu
- Laboratoire de biochimie et génétique moléculaire; Hôpital Cochin; Paris France
| | - S. Lyonnet
- Laboratory of Embryology and Genetics of Congenital Malformations, Institut National de la Santé et de la Recherche Médicale (INSERM) UMR 1163; Institut Imagine; Paris France
- Paris Descartes-Sorbonne Paris Cité University; Institut Imagine; Paris France
- Département de Génétique, Hôpital Necker-Enfants Malades; Assistance Publique Hôpitaux de Paris (AP-HP); Paris France
| | - L. de Pontual
- Laboratory of Embryology and Genetics of Congenital Malformations, Institut National de la Santé et de la Recherche Médicale (INSERM) UMR 1163; Institut Imagine; Paris France
- Service de pédiatrie; Hôpital Jean Verdier; Bondy France
| | - J. Amiel
- Laboratory of Embryology and Genetics of Congenital Malformations, Institut National de la Santé et de la Recherche Médicale (INSERM) UMR 1163; Institut Imagine; Paris France
- Paris Descartes-Sorbonne Paris Cité University; Institut Imagine; Paris France
- Département de Génétique, Hôpital Necker-Enfants Malades; Assistance Publique Hôpitaux de Paris (AP-HP); Paris France
| |
Collapse
|
17
|
Lehman N, Mazery AC, Visier A, Baumann C, Lachesnais D, Capri Y, Toutain A, Odent S, Mikaty M, Goizet C, Taupiac E, Jacquemont ML, Sanchez E, Schaefer E, Gatinois V, Faivre L, Minot D, Kayirangwa H, Sang KHLQ, Boddaert N, Bayard S, Lacombe D, Moutton S, Touitou I, Rio M, Amiel J, Lyonnet S, Sanlaville D, Picot MC, Geneviève D. Molecular, clinical and neuropsychological study in 31 patients with Kabuki syndrome and KMT2D mutations. Clin Genet 2017; 92:298-305. [PMID: 28295206 DOI: 10.1111/cge.13010] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2016] [Revised: 02/17/2017] [Accepted: 03/06/2017] [Indexed: 01/09/2023]
Abstract
Kabuki syndrome (KS-OMIM 147920) is a rare developmental disease characterized by the association of multiple congenital anomalies and intellectual disability. This study aimed to investigate intellectual performance in children with KS and link the performance to several clinical features and molecular data. We recruited 31 children with KMT2D mutations who were 6 to 16 years old. They all completed the Weschler Intelligence Scale for Children, fourth edition. We calculated all indexes: the Full Scale Intellectual Quotient (FSIQ), Verbal Comprehension Index (VCI), Perceptive Reasoning Index (PRI), Processing Speed Index (PSI), and Working Memory Index (WMI). In addition, molecular data and several clinical symptoms were studied. FSIQ and VCI scores were 10 points lower for patients with a truncating mutation than other types of mutations. In addition, scores for FSIQ, VCI and PRI were lower for children with visual impairment than normal vision. We also identified a discrepancy in indexes characterized by high WMI and VCI and low PRI and PSI. We emphasize the importance of early identification and intensive care of visual disorders in patients with KS and recommend individual assessment of intellectual profile.
Collapse
Affiliation(s)
- N Lehman
- Département de génétique médicale, maladies rares et médecine personnalisée, centre de référence anomalies du développement et syndromes malformatifs, Unité Inserm U1183, Hôpital Arnaud de Villeneuve, Université Montpellier, CHU Montpellier, Montpellier, France
| | - A C Mazery
- Service de Génétique, Hôpital Necker-Enfants Malades, AP-HP et INSERM UMR 1163, Paris Descartes-Sorbonne Paris Cité University, Institut Imagine, Paris, France
| | - A Visier
- Département de l'information médicale, CHRU Montpellier, Montpellier, France
| | - C Baumann
- Service de génétique médicale, Hôpital Robert Debré, Paris, France
| | - D Lachesnais
- Service de génétique médicale, Hôpital Robert Debré, Paris, France
| | - Y Capri
- Service de génétique médicale, Hôpital Robert Debré, Paris, France
| | - A Toutain
- Service de génétique, CHU, Tours, France
| | - S Odent
- Service de génétique clinique, Hôpital Sud CHU Rennes, Université de Rennes 1, CNRS UMR, Rennes, France
| | - M Mikaty
- Service de génétique clinique, Hôpital Sud CHU Rennes, Université de Rennes 1, CNRS UMR, Rennes, France
| | - C Goizet
- Service de génétique médicale, INSERM U1211, CHU Bordeaux, Bordeaux, France
| | - E Taupiac
- Service de génétique médicale, INSERM U1211, CHU Bordeaux, Bordeaux, France
| | - M L Jacquemont
- Unité de génétique médicale, CHU La Réunion, site GHSR, La Réunion, France
| | - E Sanchez
- Département de génétique médicale, maladies rares et médecine personnalisée, centre de référence anomalies du développement et syndromes malformatifs, Unité Inserm U1183, Hôpital Arnaud de Villeneuve, Université Montpellier, CHU Montpellier, Montpellier, France
| | - E Schaefer
- Service de génétique médicale, Institut de Génétique Médicale d'Alsace, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
| | - V Gatinois
- Département de génétique médicale, maladies rares et médecine personnalisée, centre de référence anomalies du développement et syndromes malformatifs, Unité Inserm U1183, Hôpital Arnaud de Villeneuve, Université Montpellier, CHU Montpellier, Montpellier, France
| | - L Faivre
- Centre de Génétique et Centre de Référence Anomalies du développement et Syndrome Malformatifs, CHU de Dijon et Université de Bourgogne, Dijon, France
| | - D Minot
- Centre de Génétique et Centre de Référence Anomalies du développement et Syndrome Malformatifs, CHU de Dijon et Université de Bourgogne, Dijon, France
| | - H Kayirangwa
- Service de Génétique, Hôpital Necker-Enfants Malades, AP-HP et INSERM UMR 1163, Paris Descartes-Sorbonne Paris Cité University, Institut Imagine, Paris, France
| | - K-H L Q Sang
- Service de Génétique, Hôpital Necker-Enfants Malades, AP-HP et INSERM UMR 1163, Paris Descartes-Sorbonne Paris Cité University, Institut Imagine, Paris, France
| | - N Boddaert
- Service de radiologie pédiatrique, Hôpital Necker Enfants Malades, Paris, France
| | - S Bayard
- Laboratoire Epsylon, EA 4556, Université Paul Valéry Montpellier, Montpellier, France
| | - D Lacombe
- Service de génétique médicale, INSERM U1211, CHU Bordeaux, Bordeaux, France
| | - S Moutton
- Service de génétique médicale, INSERM U1211, CHU Bordeaux, Bordeaux, France
| | - I Touitou
- Département de génétique médicale, maladies rares et médecine personnalisée, centre de référence anomalies du développement et syndromes malformatifs, Unité Inserm U1183, Hôpital Arnaud de Villeneuve, Université Montpellier, CHU Montpellier, Montpellier, France.,Laboratoire de Génétique des Maladies Rares et Maladies Auto-Inflammatoires, Hopital A de Villeneuve, Montpellier, France
| | - M Rio
- Service de Génétique, Hôpital Necker-Enfants Malades, AP-HP et INSERM UMR 1163, Paris Descartes-Sorbonne Paris Cité University, Institut Imagine, Paris, France
| | - J Amiel
- Service de Génétique, Hôpital Necker-Enfants Malades, AP-HP et INSERM UMR 1163, Paris Descartes-Sorbonne Paris Cité University, Institut Imagine, Paris, France
| | - S Lyonnet
- Service de Génétique, Hôpital Necker-Enfants Malades, AP-HP et INSERM UMR 1163, Paris Descartes-Sorbonne Paris Cité University, Institut Imagine, Paris, France
| | - D Sanlaville
- HCL, Service de génétique; Centre de Recherche en Neurosciences de Lyon, Inserm U1028, UMR CNRS 5292, GENDEV Team, Université Claude Bernard Lyon 1, Lyon, France
| | - M C Picot
- Département de l'information médicale, CHRU Montpellier, Montpellier, France
| | - D Geneviève
- Département de génétique médicale, maladies rares et médecine personnalisée, centre de référence anomalies du développement et syndromes malformatifs, Unité Inserm U1183, Hôpital Arnaud de Villeneuve, Université Montpellier, CHU Montpellier, Montpellier, France
| |
Collapse
|
18
|
Amiel J, Salomon R, Attié-Bitach T, Touraine R, Steffann J, Pelet A, Nihoul-Fékété C, Vekemans M, Munnich A, Lyonnet S. Génétique moléculaire de la maladie de Hirschsprung : un modèle de neurocristopathie multigénique. ACTA ACUST UNITED AC 2017. [DOI: 10.1051/jbio/2000194030125] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
|
19
|
Luu M, Fleck C, Hadj-Rabia S, Martin L, Bessis D, Coubes C, Willems M, Pinson L, Vincent-Delorme C, Phan A, Baujat G, Amiel J, Loffroy R, Bardou M, Faivre L, Vabres P. Essai de phase 2a du sirolimus dans les hypertrophies liées à PIK3CA (PROMISE) : données préliminaires de tolérance dans la cohorte française. Ann Dermatol Venereol 2016. [DOI: 10.1016/j.annder.2016.09.638] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
20
|
Prader R, De Broca B, Amiel J, Chevallier D, Durand M. Impact des antiagrégants plaquettaires sur la durée de séjour des patients opérés d’une résection transurétrale de tumeur de vessie. Prog Urol 2016. [DOI: 10.1016/j.purol.2016.07.075] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
21
|
Mbeutcha A, Lam Cham Kee D, Chauveinc L, Chand M, Durand M, Chevallier D, Amiel J, Bondiau P, Hannoun-Lévi J. Ré-irradiation prostatique par Cyberknife® et curiethérapie à haut débit de dose en rattrapage des récidives locales de tumeur de prostate. Prog Urol 2016. [DOI: 10.1016/j.purol.2016.07.250] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
22
|
Colomb F, Tibi B, Chevallier D, Amiel J, Durand M. Prise en charge ambulatoire préférentielle par résection Greenlight® : étude observationnelle prospective menée sur 100 patients en fonction de l’âge. Prog Urol 2016. [DOI: 10.1016/j.purol.2016.07.229] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
23
|
Haider R, Regnier P, Roustan F, Severac F, Treacy P, Mendel L, Bodokh Y, Tibi B, Prader R, Chevallier D, Amiel J, Durand M. Nephrolithotomie percutanée des calculs rénaux de plus de 2cm des personnes âgées, une technique sûre et efficace. Prog Urol 2016. [DOI: 10.1016/j.purol.2016.07.180] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
24
|
Lefebvre M, Sanlaville D, Marle N, Thauvin-Robinet C, Gautier E, Chehadeh SE, Mosca-Boidron AL, Thevenon J, Edery P, Alex-Cordier MP, Till M, Lyonnet S, Cormier-Daire V, Amiel J, Philippe A, Romana S, Malan V, Afenjar A, Marlin S, Chantot-Bastaraud S, Bitoun P, Heron B, Piparas E, Morice-Picard F, Moutton S, Chassaing N, Vigouroux-Castera A, Lespinasse J, Manouvrier-Hanu S, Boute-Benejean O, Vincent-Delorme C, Petit F, Meur NL, Marti-Dramard M, Guerrot AM, Goldenberg A, Redon S, Ferrec C, Odent S, Caignec CL, Mercier S, Gilbert-Dussardier B, Toutain A, Arpin S, Blesson S, Mortemousque I, Schaefer E, Martin D, Philip N, Sigaudy S, Busa T, Missirian C, Giuliano F, Benailly HK, Kien PKV, Leheup B, Benneteau C, Lambert L, Caumes R, Kuentz P, François I, Heron D, Keren B, Cretin E, Callier P, Julia S, Faivre L. Genetic counselling difficulties and ethical implications of incidental findings from array-CGH: a 7-year national survey. Clin Genet 2016; 89:630-5. [PMID: 26582393 DOI: 10.1111/cge.12696] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2015] [Revised: 11/11/2015] [Accepted: 11/16/2015] [Indexed: 11/29/2022]
Abstract
Microarray-based comparative genomic hybridization (aCGH) is commonly used in diagnosing patients with intellectual disability (ID) with or without congenital malformation. Because aCGH interrogates with the whole genome, there is a risk of being confronted with incidental findings (IF). In order to anticipate the ethical issues of IF with the generalization of new genome-wide analysis technologies, we questioned French clinicians and cytogeneticists about the situations they have faced regarding IF from aCGH. Sixty-five IF were reported. Forty corresponded to autosomal dominant diseases with incomplete penetrance, 7 to autosomal dominant diseases with complete penetrance, 14 to X-linked diseases, and 4 were heterozygotes for autosomal recessive diseases with a high prevalence of heterozygotes in the population. Therapeutic/preventive measures or genetic counselling could be argued for all cases except four. These four IF were intentionally not returned to the patients. Clinicians reported difficulties in returning the results in 29% of the cases, mainly when the question of IF had not been anticipated. Indeed, at the time of the investigation, only 48% of the clinicians used consents mentioning the risk of IF. With the emergence of new technologies, there is a need to report such national experiences; they show the importance of pre-test information on IF.
Collapse
Affiliation(s)
- M Lefebvre
- Centre de Génétique et Centre de Référence Anomalies du Développement et Syndromes Malformatifs de l'Est, FHU-TRANSLAD, Dijon, France.,Génétique des Anomalies du Développement, Université de Bourgogne, Dijon, France.,FHU-TRANSLAD, Université de Bourgogne, Dijon, France
| | - D Sanlaville
- Genetics Service, Hospices Civils de Lyon, Hôpital Femme-Mère-Enfant, and Eastern Biology and Pathology Centre, Lyon, France
| | - N Marle
- Centre de Génétique et Centre de Référence Anomalies du Développement et Syndromes Malformatifs de l'Est, FHU-TRANSLAD, Dijon, France.,Génétique des Anomalies du Développement, Université de Bourgogne, Dijon, France
| | - C Thauvin-Robinet
- Centre de Génétique et Centre de Référence Anomalies du Développement et Syndromes Malformatifs de l'Est, FHU-TRANSLAD, Dijon, France.,Génétique des Anomalies du Développement, Université de Bourgogne, Dijon, France.,FHU-TRANSLAD, Université de Bourgogne, Dijon, France
| | - E Gautier
- Centre de Génétique et Centre de Référence Anomalies du Développement et Syndromes Malformatifs de l'Est, FHU-TRANSLAD, Dijon, France.,FHU-TRANSLAD, Université de Bourgogne, Dijon, France
| | - S E Chehadeh
- Centre de Génétique et Centre de Référence Anomalies du Développement et Syndromes Malformatifs de l'Est, FHU-TRANSLAD, Dijon, France.,Génétique des Anomalies du Développement, Université de Bourgogne, Dijon, France
| | - A-L Mosca-Boidron
- Centre de Génétique et Centre de Référence Anomalies du Développement et Syndromes Malformatifs de l'Est, FHU-TRANSLAD, Dijon, France.,Génétique des Anomalies du Développement, Université de Bourgogne, Dijon, France
| | - J Thevenon
- Centre de Génétique et Centre de Référence Anomalies du Développement et Syndromes Malformatifs de l'Est, FHU-TRANSLAD, Dijon, France.,Génétique des Anomalies du Développement, Université de Bourgogne, Dijon, France.,FHU-TRANSLAD, Université de Bourgogne, Dijon, France
| | - P Edery
- Genetics Service, Hospices Civils de Lyon, Hôpital Femme-Mère-Enfant, and Eastern Biology and Pathology Centre, Lyon, France
| | - M-P Alex-Cordier
- Genetics Service, Hospices Civils de Lyon, Hôpital Femme-Mère-Enfant, and Eastern Biology and Pathology Centre, Lyon, France
| | - M Till
- Genetics Service, Hospices Civils de Lyon, Hôpital Femme-Mère-Enfant, and Eastern Biology and Pathology Centre, Lyon, France
| | - S Lyonnet
- Département de Génétique, Hôpital Necker-Enfants Malades, Paris, France
| | - V Cormier-Daire
- Département de Génétique, Hôpital Necker-Enfants Malades, Paris, France
| | - J Amiel
- Département de Génétique, Hôpital Necker-Enfants Malades, Paris, France
| | - A Philippe
- Département de Génétique, Hôpital Necker-Enfants Malades, Paris, France
| | - S Romana
- Département de Génétique, Hôpital Necker-Enfants Malades, Paris, France
| | - V Malan
- Département de Génétique, Hôpital Necker-Enfants Malades, Paris, France
| | - A Afenjar
- Service de Génétique, Hôpital Pitié Salpêtrière, Paris, France
| | - S Marlin
- Département de Génétique, Hôpital Necker-Enfants Malades, Paris, France
| | - S Chantot-Bastaraud
- APHP, Hôpital Armand Trousseau, Service de Génétique et d'Embryologie Médicales, Paris, France
| | - P Bitoun
- Service de Pédiatrie, Hôpital Jean Verdier, Assistance Publique - Hôpitaux de Paris, Paris, France
| | - B Heron
- Department of Neuropediatrics, Armand Trousseau Hospital, APHP, Paris, France
| | - E Piparas
- Cytogenetics Laboratory, Jean Verdier Hospital, Bondy, France
| | - F Morice-Picard
- Department of Clinical Genetics, Bordeaux Children's Hospital, CHU de Bordeaux, Bordeaux, France
| | - S Moutton
- Department of Clinical Genetics, Bordeaux Children's Hospital, CHU de Bordeaux, Bordeaux, France
| | - N Chassaing
- Service de Génétique Médicale, Hôpital Purpan, CHU Toulouse, Université Paul Sabatier Toulouse, Toulouse, France
| | - A Vigouroux-Castera
- Service de Génétique Médicale, Hôpital Purpan, CHU Toulouse, Université Paul Sabatier Toulouse, Toulouse, France
| | - J Lespinasse
- Cytogenetics Laboratory, Chambery Hospital, Chambery, France
| | - S Manouvrier-Hanu
- Service de Génétique Clinique, Hôpital Jeanne de Flandre, CHRU, Lille, France
| | - O Boute-Benejean
- Service de Génétique Clinique, Hôpital Jeanne de Flandre, CHRU, Lille, France
| | - C Vincent-Delorme
- Service de Génétique Clinique, Hôpital Jeanne de Flandre, CHRU, Lille, France
| | - F Petit
- Service de Génétique Clinique, Hôpital Jeanne de Flandre, CHRU, Lille, France
| | - N L Meur
- Cytogenetics Laboratory, Etablissement Français du Sang de Normandie, Rouen, France
| | - M Marti-Dramard
- Unité de Génétique Clinique, Hôpital Nord, CHU, Amiens, France
| | - A-M Guerrot
- Service de Pédiatrie Néonatale et Réanimation, Centre D'éducation Fonctionnelle de l'enfant, CHU de Rouen, Rouen, France
| | - A Goldenberg
- Unité de Génétique Médicale, CHU Rouen, Rouen, France
| | - S Redon
- Laboratoire de Génétique Moléculaire, CHU, Brest, France
| | - C Ferrec
- Laboratoire de Génétique Moléculaire, CHU, Brest, France
| | - S Odent
- Service de Génétique Clinique, CLAD-Ouest, Hôpital Sud, Rennes, France
| | - C L Caignec
- Service de Génétique Médicale, Unité de Génétique Clinique, CLAD-Ouest, CHU de Nantes, Nantes, France
| | - S Mercier
- Service de Génétique Médicale, Unité de Génétique Clinique, CLAD-Ouest, CHU de Nantes, Nantes, France
| | | | - A Toutain
- Service de Génétique, Centre Hospitalo-Universitaire, Tours, France
| | - S Arpin
- Service de Génétique, Centre Hospitalo-Universitaire, Tours, France
| | - S Blesson
- Service de Génétique, Centre Hospitalo-Universitaire, Tours, France
| | - I Mortemousque
- Service de Génétique, Centre Hospitalo-Universitaire, Tours, France
| | - E Schaefer
- Service de Génétique Médicale, Hôpital de Hautepierre, Strasbourg, France
| | - D Martin
- Service de Génétique Médicale, Hôpital du Mans, Le Mans, France
| | - N Philip
- Département de Génétique Médicale, Hôpital d'Enfants de La Timone, Marseille, France
| | - S Sigaudy
- Département de Génétique Médicale, Hôpital d'Enfants de La Timone, Marseille, France
| | - T Busa
- Département de Génétique Médicale, Hôpital d'Enfants de La Timone, Marseille, France
| | - C Missirian
- Département de Génétique Médicale, Hôpital d'Enfants de La Timone, Marseille, France
| | - F Giuliano
- Service de Génétique Médicale, Hôpital de l'Archet II, CHU de Nice, Nice, France
| | - H K Benailly
- Service de Génétique Médicale, Hôpital de l'Archet II, CHU de Nice, Nice, France
| | - P K V Kien
- Service de Génétique Médicale, Hôpital Caremeau, CHU de Nimes, Nimes, France
| | - B Leheup
- CHU de Nancy Pole Enfant, Centre de Référence Maladies Rares CLAD Est, Service de Médecine Infantile III et Génétique Clinique, Nancy, France
| | - C Benneteau
- CHU de Nancy Pole Enfant, Centre de Référence Maladies Rares CLAD Est, Service de Médecine Infantile III et Génétique Clinique, Nancy, France
| | - L Lambert
- CHU de Nancy Pole Enfant, Centre de Référence Maladies Rares CLAD Est, Service de Médecine Infantile III et Génétique Clinique, Nancy, France
| | - R Caumes
- APHP, Hôpital Robert Debré, Service de Neurologie Pédiatrique, Paris, France
| | - P Kuentz
- Service de génétique, Centre Hospitalier Universitaire de Besançon, Besançon, France
| | | | - D Heron
- Service de Génétique, APHP, Groupe Hospitalier de la Pitié-Salpétrière, Paris, France
| | - B Keren
- Service de Génétique, APHP, Groupe Hospitalier de la Pitié-Salpétrière, Paris, France
| | - E Cretin
- FHU-TRANSLAD, Université de Bourgogne, Dijon, France.,Espace Régional Éthique Bourgogne-Franche Comté, CHU, Besançon, France
| | - P Callier
- Centre de Génétique et Centre de Référence Anomalies du Développement et Syndromes Malformatifs de l'Est, FHU-TRANSLAD, Dijon, France.,Génétique des Anomalies du Développement, Université de Bourgogne, Dijon, France.,FHU-TRANSLAD, Université de Bourgogne, Dijon, France
| | - S Julia
- Service de Génétique Médicale, Hôpital Purpan, CHU Toulouse, Université Paul Sabatier Toulouse, Toulouse, France
| | - L Faivre
- Centre de Génétique et Centre de Référence Anomalies du Développement et Syndromes Malformatifs de l'Est, FHU-TRANSLAD, Dijon, France.,Génétique des Anomalies du Développement, Université de Bourgogne, Dijon, France.,FHU-TRANSLAD, Université de Bourgogne, Dijon, France
| |
Collapse
|
25
|
Avila M, Dyment DA, Sagen JV, St-Onge J, Moog U, Chung BHY, Mo S, Mansour S, Albanese A, Garcia S, Martin DO, Lopez AA, Claudi T, König R, White SM, Sawyer SL, Bernstein JA, Slattery L, Jobling RK, Yoon G, Curry CJ, Merrer ML, Luyer BL, Héron D, Mathieu-Dramard M, Bitoun P, Odent S, Amiel J, Kuentz P, Thevenon J, Laville M, Reznik Y, Fagour C, Nunes ML, Delesalle D, Manouvrier S, Lascols O, Huet F, Binquet C, Faivre L, Rivière JB, Vigouroux C, Njølstad PR, Innes AM, Thauvin-Robinet C. Clinical reappraisal of SHORT syndrome with PIK3R1 mutations: toward recommendation for molecular testing and management. Clin Genet 2015; 89:501-506. [PMID: 26497935 DOI: 10.1111/cge.12688] [Citation(s) in RCA: 53] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2015] [Revised: 10/10/2015] [Accepted: 10/16/2015] [Indexed: 12/01/2022]
Abstract
SHORT syndrome has historically been defined by its acronym: short stature (S), hyperextensibility of joints and/or inguinal hernia (H), ocular depression (O), Rieger abnormality (R) and teething delay (T). More recently several research groups have identified PIK3R1 mutations as responsible for SHORT syndrome. Knowledge of the molecular etiology of SHORT syndrome has permitted a reassessment of the clinical phenotype. The detailed phenotypes of 32 individuals with SHORT syndrome and PIK3R1 mutation, including eight newly ascertained individuals, were studied to fully define the syndrome and the indications for PIK3R1 testing. The major features described in the SHORT acronym were not universally seen and only half (52%) had four or more of the classic features. The commonly observed clinical features of SHORT syndrome seen in the cohort included intrauterine growth restriction (IUGR) <10th percentile, postnatal growth restriction, lipoatrophy and the characteristic facial gestalt. Anterior chamber defects and insulin resistance or diabetes were also observed but were not as prevalent. The less specific, or minor features of SHORT syndrome include teething delay, thin wrinkled skin, speech delay, sensorineural deafness, hyperextensibility of joints and inguinal hernia. Given the high risk of diabetes mellitus, regular monitoring of glucose metabolism is warranted. An echocardiogram, ophthalmological and hearing assessments are also recommended.
Collapse
Affiliation(s)
- M Avila
- EA4271 "Génétique des Anomalies du Développement" (GAD), Université de Bourgogne, Dijon, France.,Service de Pédiatrie 1, Centre Hospitalier Universitaire Dijon, Dijon, France
| | - D A Dyment
- Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Canada
| | - J V Sagen
- Hormone Laboratory, Haukeland University Hospital, Bergen, Norway.,KJ Jebsen Center for Diabetes Research, Department of Clinical Science, University of Bergen, Bergen, Norway
| | - J St-Onge
- EA4271 "Génétique des Anomalies du Développement" (GAD), Université de Bourgogne, Dijon, France.,CHU Dijon, Laboratoire de Génétique Moléculaire, Dijon, France
| | - U Moog
- Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany
| | - B H Y Chung
- Department of Paediatrics and Adolescent Medicine, The University of Hong Kong - Shenzhen Hospital, Shenzhen, China
| | - S Mo
- Department of Paediatrics and Adolescent Medicine, The University of Hong Kong - Shenzhen Hospital, Shenzhen, China
| | - S Mansour
- SW Thames Regional Genetics Service, St. George's Hospital Medical School, London, SW17 0RE, UK
| | - A Albanese
- Paediatric Endocrine Unit, St George's Hospital, London, UK
| | - S Garcia
- Institute of Medical and Molecular Genetics (INGEMM), La Paz University Hospital, Madrid, Spain.,Instituto de Salud Carlos III, Unit 753, Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER), Madrid, Spain
| | - D O Martin
- Department of Ophthalmology, Hospital Central de la Cruz Roja San Jose y Santa Adela, Madrid, Spain
| | - A A Lopez
- Puerta de Hierro, University Hospital, Madrid, Spain
| | - T Claudi
- Department of Medicine, Bodø, Norway
| | - R König
- Department of Human Genetics, University of Frankfurt, Frankfurt, Germany
| | - S M White
- Victorian Clinical genetics Services, Murdoch Childrens Research institute, Parkville, Australia.,Department of Paediatrics, University of Melbourne, Melbourne, Australia
| | - S L Sawyer
- Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Canada
| | - J A Bernstein
- Division of Medical Genetics, Department of Pediatrics, Stanford University, Stanford, CA, USA
| | - L Slattery
- Division of Medical Genetics, Department of Pediatrics, Stanford University, Stanford, CA, USA
| | - R K Jobling
- Division of Clinical and Metabolic Genetics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada
| | - G Yoon
- Division of Clinical and Metabolic Genetics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada
| | - C J Curry
- Genetic Medicine/, University of California, San Francisco, CA, USA
| | - M L Merrer
- Département de Génétique, Hôpital Necker Enfants Malades, Paris, France
| | - B L Luyer
- Service de Pédiatrie, CH Le Havre, Le Havre, France
| | - D Héron
- Département de Génétique et Centre de Référence "Déficiences intellectuelles de causes rares", Paris, France
| | | | - P Bitoun
- Service de Pédiatrie, Bondy, France
| | - S Odent
- Service de Génétique clinique, Rennes, France.,UMR CNRS 6290 IGDR, Universitė Rennes, Rennes, France
| | - J Amiel
- Département de Génétique, Hôpital Necker Enfants Malades, Paris, France
| | - P Kuentz
- EA4271 "Génétique des Anomalies du Développement" (GAD), Université de Bourgogne, Dijon, France
| | - J Thevenon
- EA4271 "Génétique des Anomalies du Développement" (GAD), Université de Bourgogne, Dijon, France.,Centre de Génétique et Centre de Référence Anomalies du Développement et Syndromes Malformatifs de l'interrégion Est, FHU-TRANSLAD, Dijon, France
| | - M Laville
- Département d'Endocrinologie, Diabétologie et Nutrition, Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France.,Institut National de la Santé et de la Recherche Médicale Unité 1060, Centre Européen pour la nutrition et la Santé, Centre de Recherche en Nutrition Humaine Rhône-Alpes, Université Claude Bernard Lyon, Pierre-Bénite, France
| | - Y Reznik
- Service d'Endocrinologie, Centre Hospitalier Universitaire Côte-de-Nacre, Caen, France
| | - C Fagour
- Département d'Endocrinologie, Hôpital Haut-Lévêque, Centre Hospitalier Universitaire de Bordeaux, Pessac, France
| | - M-L Nunes
- Département d'Endocrinologie, Hôpital Haut-Lévêque, Centre Hospitalier Universitaire de Bordeaux, Pessac, France
| | - D Delesalle
- Service de pédiatrie, CH de Valencienne, Valencienne, France
| | - S Manouvrier
- Centre de Référence CLAD NdF - Service de génétique clinique Guy Fontaine, CHRU de Lille - Hôpital Jeanne de Flandre, Lille, France
| | - O Lascols
- INSERM, UMR_S938, Centre de Recherche Saint-Antoine, Paris, France.,UPMC Univ Paris 06, Paris, France.,ICAN, Institute of Cardiometabolism And Nutrition, Groupe Hospitalier Universitaire La Pitié-Salpêtrière, Paris, France.,AP-HP, Hôpital Saint-Antoine, Laboratoire Commun de Biologie et Génétique Moléculaires, Paris, France
| | - F Huet
- EA4271 "Génétique des Anomalies du Développement" (GAD), Université de Bourgogne, Dijon, France.,Service de Pédiatrie 1, Centre Hospitalier Universitaire Dijon, Dijon, France
| | - C Binquet
- Centre d'Investigation Clinique-Epidémiologique Clinique/essais cliniques du CHU de Dijon, Dijon, France
| | - L Faivre
- EA4271 "Génétique des Anomalies du Développement" (GAD), Université de Bourgogne, Dijon, France.,Centre de Génétique et Centre de Référence Anomalies du Développement et Syndromes Malformatifs de l'interrégion Est, FHU-TRANSLAD, Dijon, France
| | - J-B Rivière
- EA4271 "Génétique des Anomalies du Développement" (GAD), Université de Bourgogne, Dijon, France.,CHU Dijon, Laboratoire de Génétique Moléculaire, Dijon, France
| | - C Vigouroux
- INSERM, UMR_S938, Centre de Recherche Saint-Antoine, Paris, France.,UPMC Univ Paris 06, Paris, France.,ICAN, Institute of Cardiometabolism And Nutrition, Groupe Hospitalier Universitaire La Pitié-Salpêtrière, Paris, France.,AP-HP, Hôpital Saint-Antoine, Laboratoire Commun de Biologie et Génétique Moléculaires, Paris, France
| | - P R Njølstad
- Department of Pediatrics, Haukeland, University Hospital, Bergen, Norway
| | - A M Innes
- Department of Medical Genetics, University of Calgary, Calgary, Canada.,Alberta Children's Hospital Research Institute for Child and Maternal Health, University of Calgary, Calgary, Canada
| | - C Thauvin-Robinet
- EA4271 "Génétique des Anomalies du Développement" (GAD), Université de Bourgogne, Dijon, France.,Centre de Génétique et Centre de Référence Anomalies du Développement et Syndromes Malformatifs de l'interrégion Est, FHU-TRANSLAD, Dijon, France
| |
Collapse
|
26
|
Lotte L, Lotte R, Durand M, Degand N, Ambrosetti D, Michiels JF, Amiel J, Cattoir V, Ruimy R. Infections related to Actinotignum schaalii (formerly Actinobaculum schaalii): a 3-year prospective observational study on 50 cases. Clin Microbiol Infect 2015; 22:388-390. [PMID: 26551841 DOI: 10.1016/j.cmi.2015.10.030] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2015] [Accepted: 10/29/2015] [Indexed: 11/17/2022]
Affiliation(s)
- L Lotte
- Department of Bacteriology at Nice Academic Hospital, Nice, France
| | - R Lotte
- Department of Bacteriology at Nice Academic Hospital, Nice, France; Nice Medical University, Nice-Sophia Antipolis University, Nice, France; INSERM 1065(C3M), Team6, Bâtiment universitaire Archimed, Nice, France.
| | - M Durand
- Nice Medical University, Nice-Sophia Antipolis University, Nice, France; Department of Urology at Nice Academic Hospital, Nice, France
| | - N Degand
- Department of Bacteriology at Nice Academic Hospital, Nice, France
| | - D Ambrosetti
- Nice Medical University, Nice-Sophia Antipolis University, Nice, France; Department of Pathology at Nice Academic Hospital, Nice, France
| | - J-F Michiels
- Nice Medical University, Nice-Sophia Antipolis University, Nice, France; Department of Pathology at Nice Academic Hospital, Nice, France
| | - J Amiel
- Nice Medical University, Nice-Sophia Antipolis University, Nice, France; Department of Urology at Nice Academic Hospital, Nice, France
| | - V Cattoir
- Department of Bacteriology at Caen Academic Hospital, Caen, France; National Reference Centre for Antimicrobial Resistance (lab 'Enterococci'), Caen, France; University of Caen Basse-Normandie, EA 4655 U2RM (team 'Antibioresistance'), Caen, France
| | - R Ruimy
- Department of Bacteriology at Nice Academic Hospital, Nice, France; Nice Medical University, Nice-Sophia Antipolis University, Nice, France; INSERM 1065(C3M), Team6, Bâtiment universitaire Archimed, Nice, France
| |
Collapse
|
27
|
Tibi B, Vincens E, Durand M, Salet-Lizet D, Gadonneix P, Kane A, Carpentier X, Marsaud A, Rouscoff Y, Chevallier D, Amiel J, Villet R. Quelle est la meilleure prise en charge chirurgicale du prolapsus chez la femme âgée de 70 à 80ans ? Prog Urol 2015; 25:843. [DOI: 10.1016/j.purol.2015.08.255] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
28
|
Lehalle D, Wieczorek D, Zechi-Ceide RM, Passos-Bueno MR, Lyonnet S, Amiel J, Gordon CT. A review of craniofacial disorders caused by spliceosomal defects. Clin Genet 2015; 88:405-15. [PMID: 25865758 DOI: 10.1111/cge.12596] [Citation(s) in RCA: 70] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2015] [Revised: 03/26/2015] [Accepted: 04/07/2015] [Indexed: 02/04/2023]
Abstract
The spliceosome is a large ribonucleoprotein complex that removes introns from pre-mRNA transcripts. Mutations in EFTUD2, encoding a component of the major spliceosome, have recently been identified as the cause of mandibulofacial dysostosis, Guion-Almeida type (MFDGA), characterized by mandibulofacial dysostosis, microcephaly, external ear malformations and intellectual disability. Mutations in several other genes involved in spliceosomal function or linked aspects of mRNA processing have also recently been identified in human disorders with specific craniofacial malformations: SF3B4 in Nager syndrome, an acrofacial dysostosis (AFD); SNRPB in cerebrocostomandibular syndrome, characterized by Robin sequence and rib defects; EIF4A3 in the AFD Richieri-Costa-Pereira syndrome, characterized by Robin sequence, median mandibular cleft and limb defects; and TXNL4A in Burn-McKeown syndrome, involving specific craniofacial dysmorphisms. Here, we review phenotypic and molecular aspects of these syndromes. Given the apparent sensitivity of craniofacial development to defects in mRNA processing, it is possible that mutations in other proteins involved in spliceosomal function will emerge in the future as causative for related human disorders.
Collapse
Affiliation(s)
- D Lehalle
- Department of Genetics, APHP, Hôpital Necker-Enfants Malades, Paris, France
| | - D Wieczorek
- Institut für Humangenetik, Universitätsklinikum Essen, Essen, Germany
| | - R M Zechi-Ceide
- Departamento de Genetica Clinica, Hospital de Reabilitacao de Anomalias Craniofaciais, Universidade de Sao Paulo (HRAC-USP), Bauru, Brasil
| | - M R Passos-Bueno
- Centro de Estudos do Genoma Humano, Instituto de Biociencias, Universidade de Sao Paulo, Sao Paulo, Brasil
| | - S Lyonnet
- Department of Genetics, APHP, Hôpital Necker-Enfants Malades, Paris, France.,INSERM UMR 1163, Institut Imagine, Paris, France.,Université Paris Descartes-Sorbonne Paris Cité, Institut Imagine, Paris, France
| | - J Amiel
- Department of Genetics, APHP, Hôpital Necker-Enfants Malades, Paris, France.,INSERM UMR 1163, Institut Imagine, Paris, France.,Université Paris Descartes-Sorbonne Paris Cité, Institut Imagine, Paris, France
| | - C T Gordon
- INSERM UMR 1163, Institut Imagine, Paris, France.,Université Paris Descartes-Sorbonne Paris Cité, Institut Imagine, Paris, France
| |
Collapse
|
29
|
Marsaud A, Durand M, Raffaelli C, Carpentier X, Rouscoff Y, Tibi B, Floc’h A, De Villeneuve M, Haider R, Ambrosetti D, Fontas E, Padovani B, Amiel J, Chevallier D. Apport de l’élastographie en temps réel pour la caractérisation des masses testiculaires. Prog Urol 2015; 25:75-82. [DOI: 10.1016/j.purol.2014.11.008] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2013] [Revised: 10/10/2014] [Accepted: 11/28/2014] [Indexed: 12/21/2022]
|
30
|
Tibi B, Durand M, Rouscoff Y, Lee J, Mauduit C, Ambrosetti D, Mahate Z, Wijeratne V, Severac F, Carpentier X, Marsaud A, Mentine N, Quintens H, Amiel J, Chevallier D, Benahmed M. Évaluation du profil plasmatique des microARNs, comme marqueur diagnostic du cancer localisé de la prostate avec confirmation des analyses par prélèvement tissulaire sur spécimens après prostatectomie radicale élargie. Prog Urol 2014; 24:787-8. [DOI: 10.1016/j.purol.2014.08.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
31
|
Chevallier D, Amiel J. Prise en charge médicale des symptômes du bas appareil urinaire (SBAU) en rapport avec une hyperplasie bénigne de la prostate (HBP) (SBAU-HBP) : Impact sur la fonction sexuelle - Revue de la littérature. Sexologies 2014. [DOI: 10.1016/j.sexol.2014.07.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
32
|
Al-Mamari SA, Jourdan J, Boukaidi S, Quintens H, Marsaud A, Carpentier X, Arnaud P, Mentine N, Durand M, Amiel J, Chevallier D. [Ipsilateral dual kidney transplantation: a monocentric experience about 15 cases and literature review]. Prog Urol 2014; 24:87-93. [PMID: 24485077 DOI: 10.1016/j.purol.2013.09.004] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2013] [Revised: 08/01/2013] [Accepted: 09/09/2013] [Indexed: 11/25/2022]
Abstract
OBJECTIVE Our study aimed to support the viability of the concept of Ipsilateral Dual Kidney Transplantation (DKT) by presenting our initial experience and proposing a review of the literature in this subject. METHODS Fifteen ipsilateral DKT were performed at Nice University Hospital between August 2010 and March 2012. We have described our skin incision preferences, the vascular anastomoses, and the uretero-vesical reimplantation. We have analyzed the operative duration, the cold ischemia time (CIT) of both transplants, the blood transfusion volume, the intraoperative and postoperative complications, the time to diuresis recovery, the hospital stay, and the kinetics of the creatinine clearance until the third postoperative month. We have compared our results with those of the literature. RESULTS The average CIT of the first transplant (T1) was 17.5 ± 3.3 hours, and that of the second (T2) was 18.4 ± 3.3 hours. The mean operating time was 234 ± 67 minutes. Patients received an average of 2 units of blood during surgery [0-4] and 1.8 units in the postoperative period [0-15]. The complications rate was 26.7% and included an intraoperative T2 artery thrombosis and 3 postoperative complications consistent with a hematoma, a T2 ureteric necrosis and a T2 venous thrombosis. Two transplants were lost (6.7%) and one death (6.7%) was reported on day 40. The average length of hospital stay was 20.9 ± 7.8 days. The mean creatinine clearance values were 12.6 mL/min at D2, 35.6 mL/min at D7, 44.9 mL/min on discharge, and 48.2 mL/min at D90. CONCLUSION Our results supported the viability of the dual kidney transplantation concept. Furthermore the ipsilateral approach shortened the procedure and limited the surgical trauma by preserving the contralateral iliac fossa, without compromising renal function recovery or increasing morbidity.
Collapse
Affiliation(s)
- S A Al-Mamari
- Service d'urologie, hôpital l'Archet 2, CHU de Nice, 151, route Saint-Antoine-de-Ginestière, BP 06202, 23079 Nice cedex 3, France.
| | - J Jourdan
- Service d'urologie, hôpital l'Archet 2, CHU de Nice, 151, route Saint-Antoine-de-Ginestière, BP 06202, 23079 Nice cedex 3, France
| | - S Boukaidi
- Service d'urologie, hôpital l'Archet 2, CHU de Nice, 151, route Saint-Antoine-de-Ginestière, BP 06202, 23079 Nice cedex 3, France
| | - H Quintens
- Service d'urologie, hôpital l'Archet 2, CHU de Nice, 151, route Saint-Antoine-de-Ginestière, BP 06202, 23079 Nice cedex 3, France
| | - A Marsaud
- Service d'urologie, hôpital l'Archet 2, CHU de Nice, 151, route Saint-Antoine-de-Ginestière, BP 06202, 23079 Nice cedex 3, France
| | - X Carpentier
- Service d'urologie, hôpital l'Archet 2, CHU de Nice, 151, route Saint-Antoine-de-Ginestière, BP 06202, 23079 Nice cedex 3, France
| | - P Arnaud
- Service d'urologie, hôpital l'Archet 2, CHU de Nice, 151, route Saint-Antoine-de-Ginestière, BP 06202, 23079 Nice cedex 3, France
| | - N Mentine
- Service d'urologie, hôpital l'Archet 2, CHU de Nice, 151, route Saint-Antoine-de-Ginestière, BP 06202, 23079 Nice cedex 3, France
| | - M Durand
- Service d'urologie, hôpital l'Archet 2, CHU de Nice, 151, route Saint-Antoine-de-Ginestière, BP 06202, 23079 Nice cedex 3, France
| | - J Amiel
- Service d'urologie, hôpital l'Archet 2, CHU de Nice, 151, route Saint-Antoine-de-Ginestière, BP 06202, 23079 Nice cedex 3, France
| | - D Chevallier
- Service d'urologie, hôpital l'Archet 2, CHU de Nice, 151, route Saint-Antoine-de-Ginestière, BP 06202, 23079 Nice cedex 3, France
| |
Collapse
|
33
|
Tibi B, Quintens H, Carpentier X, Albano L, Durand M, Amiel J. Évaluation des différentes techniques d’excision de la collerette vésicale lors des néphro-urétérectomies laparoscopiques pour la prise en charge des carcinomes urothéliaux de la voie excrétrice supérieure. Prog Urol 2014; 24:94-101. [DOI: 10.1016/j.purol.2013.08.320] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2013] [Revised: 08/03/2013] [Accepted: 08/26/2013] [Indexed: 11/27/2022]
|
34
|
Trang H, Amiel J, Straus C. [Spotlight on the congenital central hypoventilation syndrome (Ondine's curse) and its management]. Rev Mal Respir 2013; 30:609-12. [PMID: 24182648 DOI: 10.1016/j.rmr.2013.07.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/24/2013] [Accepted: 06/27/2013] [Indexed: 10/26/2022]
Affiliation(s)
- H Trang
- Centre de référence du syndrome d'Ondine, 75019 Paris, France; Service de physiologie-explorations fonctionnelles, hôpital Robert-Debré, Assistance publique-Hôpitaux de Paris, 75019 Paris, France.
| | | | | |
Collapse
|
35
|
Rouscoff Y, Marsaud A, Chand M, Durand M, Carpentier X, Mentine N, Tibi B, Doyen J, Chevallier D, Amiel J, Hannoun-Levi J. La curiethérapie interstitielle haut débit de dose dans le cancer du pénis T1–T2 : une véritable alternative. Prog Urol 2013. [DOI: 10.1016/j.purol.2013.08.025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
36
|
Durand M, Aggarwal A, Robinson B, Sooriakumaran P, Srivastava A, Zipfel W, Amiel J, Tewari A. La microscopie multiphotonique in vivo en temps reel : une imagerie prometteuse pour l’analyse histologique virutelle des tissus frais sans biopsie. Prog Urol 2013. [DOI: 10.1016/j.purol.2013.08.221] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
37
|
Rouscoff Y, Diagne M, Chand M, Carpentier X, Falk A, Mentine N, Durand M, Chevallier D, Amiel J, Hannoun-Levi J. High-Dose-Rate Interstitial Brachytherapy for T1-2 Penile Cancer: A Real Alternative. Int J Radiat Oncol Biol Phys 2013. [DOI: 10.1016/j.ijrobp.2013.06.1053] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
38
|
Khen-Dunlop N, Amiel J, Delacourt C, Révillon Y. [Enigmatic lymphatic diseases involving the lung]. Rev Pneumol Clin 2013; 69:260-264. [PMID: 23561737 DOI: 10.1016/j.pneumo.2013.02.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/30/2012] [Revised: 01/22/2013] [Accepted: 02/15/2013] [Indexed: 06/02/2023]
Abstract
Lymphedema associated with other developmental malformations (Milroy syndrome, Hennekam syndrome, Noonan syndrome, Gorham-Stout syndrome, yellow nail syndrome) are unfrequent disease, but explorations led to the identification of genetic mutations that have then been validated in mouse models. However, lymphatic vessels complexity and its proximity with the venous system suggest the need for further researches, especially in the comprehension of pulmonary symptoms.
Collapse
Affiliation(s)
- N Khen-Dunlop
- Service de chirurgie viscérale pédiatrique, hôpital Necker-Enfants-malades, 149, rue de Sèvres, 75015 Paris, France.
| | | | | | | |
Collapse
|
39
|
Petit F, Escande F, Jourdain AS, Porchet N, Amiel J, Doray B, Delrue MA, Flori E, Kim CA, Marlin S, Robertson SP, Manouvrier-Hanu S, Holder-Espinasse M. Nager syndrome: confirmation of SF3B4 haploinsufficiency as the major cause. Clin Genet 2013; 86:246-51. [PMID: 24003905 DOI: 10.1111/cge.12259] [Citation(s) in RCA: 52] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2013] [Revised: 07/16/2013] [Accepted: 08/19/2013] [Indexed: 11/28/2022]
Abstract
Nager syndrome belongs to the group of acrofacial dysostosis, which are characterized by the association of craniofacial and limb malformations. Recently, exome sequencing studies identified the SF3B4 gene as the cause of this condition in most patients. SF3B4 encodes a highly conserved protein implicated in mRNA splicing and bone morphogenic protein (BMP) signaling. We performed SF3B4 sequencing in 14 families (18 patients) whose features were suggestive of Nager syndrome and found nine mutations predicted to result in loss-of-function. SF3B4 is the major gene responsible for autosomal dominant Nager syndrome. All mutations reported predict null alleles, therefore precluding genotype-phenotype correlations. Most mutation-negative patients were phenotypically indistinguishable from patients with mutations, suggesting genetic heterogeneity.
Collapse
Affiliation(s)
- F Petit
- Service de Génétique Clinique, Hôpital Jeanne de Flandre, CHRU Lille, Lille, France; Laboratoire de Biologie Moléculaire, Centre de Biologie Pathologie, CHRU Lille, Lille, France; Université Lille Nord de France
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
40
|
Callier P, Aral B, Hanna N, Lambert S, Dindy H, Ragon C, Payet M, Collod-Beroud G, Carmignac V, Delrue MA, Goizet C, Philip N, Busa T, Dulac Y, Missotte I, Sznajer Y, Toutain A, Francannet C, Megarbane A, Julia S, Edouard T, Sarda P, Amiel J, Lyonnet S, Cormier-Daire V, Gilbert B, Jacquette A, Heron D, Collignon P, Lacombe D, Morice-Picard F, Jouk PS, Cusin V, Willems M, Sarrazin E, Amarof K, Coubes C, Addor MC, Journel H, Colin E, Khau Van Kien P, Baumann C, Leheup B, Martin-Coignard D, Doco-Fenzy M, Goldenberg A, Plessis G, Thevenon J, Pasquier L, Odent S, Vabres P, Huet F, Marle N, Mosca-Boidron AL, Mugneret F, Gauthier S, Binquet C, Thauvin-Robinet C, Jondeau G, Boileau C, Faivre L. Systematic molecular and cytogenetic screening of 100 patients with marfanoid syndromes and intellectual disability. Clin Genet 2013; 84:507-21. [PMID: 23506379 DOI: 10.1111/cge.12094] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2012] [Revised: 01/04/2013] [Accepted: 01/04/2013] [Indexed: 01/13/2023]
Abstract
The association of marfanoid habitus (MH) and intellectual disability (ID) has been reported in the literature, with overlapping presentations and genetic heterogeneity. A hundred patients (71 males and 29 females) with a MH and ID were recruited. Custom-designed 244K array-CGH (Agilent®; Agilent Technologies Inc., Santa Clara, CA) and MED12, ZDHHC9, UPF3B, FBN1, TGFBR1 and TGFBR2 sequencing analyses were performed. Eighty patients could be classified as isolated MH and ID: 12 chromosomal imbalances, 1 FBN1 mutation and 1 possibly pathogenic MED12 mutation were found (17%). Twenty patients could be classified as ID with other extra-skeletal features of the Marfan syndrome (MFS) spectrum: 4 pathogenic FBN1 mutations and 4 chromosomal imbalances were found (2 patients with both FBN1 mutation and chromosomal rearrangement) (29%). These results suggest either that there are more loci with genes yet to be discovered or that MH can also be a relatively non-specific feature of patients with ID. The search for aortic complications is mandatory even if MH is associated with ID since FBN1 mutations or rearrangements were found in some patients. The excess of males is in favour of the involvement of other X-linked genes. Although it was impossible to make a diagnosis in 80% of patients, these results will improve genetic counselling in families.
Collapse
Affiliation(s)
- P Callier
- Service de Cytogénétique, Plateau technique de Biologie, CHU, Dijon, France; Equipe GAD, EA 4271, Université de Bourgogne, Dijon, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
41
|
Mentine N, Boukaidi SA, Loeffler Mac-Neill J, Amiel J, Chevallier D. [Photovaporisation of the prostate using KTP laser in patients on antithrombotics. About a restrospective study of 120 cases]. Prog Urol 2013; 23:137-43. [PMID: 23352307 DOI: 10.1016/j.purol.2012.09.020] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2012] [Revised: 09/25/2012] [Accepted: 09/26/2012] [Indexed: 11/18/2022]
Abstract
UNLABELLED Antithrombotic (AT) medications are more and more prescribed, so complicating the surgery of benign prostatic hyperplasia (BPH). KTP laser is an alternative to the transurethral resection of the prostate thanks to its haemostatic properties. OBJECTIVES To study the functional outcomes and complications of KTP 80W laser treatment in patients taking AT, comparing with patients without AT (nAT). PATIENTS AND METHODS A single-center retrospective study has been conducted in the department of Urology of Nice Teaching Hospital, in patients with uncomplicated symptomatic BPH, treated with the KTP 80W laser treatment, between November 2005 and October 2009. The cohort was divided into two matched groups AT/nAT. In the AT group patients, treatment with aspirin and vitamin K antagonist (VKA) were maintained, whereas clopidogrel was discontinued. The urinary flowmetry, measurement of residual urine, International Prostate Symptom Score (IPSS) and question 8 of the IPSS score were analyzed. The duration of intervention, the amount of laser energy delivered, duration of catheterization and postoperative hospitalization, and the rate of blood transfusion have been evaluated. Clavien classification was used to characterize the postoperative complications. RESULTS A total of 120 patients were included in two groups (50 AT/70 nAT), with a median follow-up of 24 months. The two study groups were comparable except for age which was significantly higher in patients on AT (P=0.001). The average duration of operation, of catheterization and hospital stay were significantly longer in patients receiving AT. Seven complications were reported in the AT group versus three complications in the nAT. No significant difference was reported on the evaluation of voiding parameters and IPSS score. CONCLUSION Photovaporisation of the prostate using KTP 80W laser treatment provided functional outcomes comparable in patients on AT and untreated patients, with minimal risk of complication.
Collapse
Affiliation(s)
- N Mentine
- Service d'urologie, hôpital de l'Archet 2, CHU de Nice, 151, route Saint-Antoine-de-Ginestière, 06202 Nice, France.
| | | | | | | | | |
Collapse
|
42
|
Durand M, Aggarwal A, Robinson B, Sooriakumaran P, Groover S, Srivastava A, Mtui J, Brooks D, Flomenbaum D, Sterling J, Leung R, Herman M, Zipfel W, Webb W, Maxfield F, Mukherjee S, Arnaud P, Bensaid R, Mentine N, Rouscoff Y, Carpentier X, Chevallier D, Amiel J, Tewari AK. L’imagerie multiphotonique in vivo de la capsule prostatique : un outil prometteur pour la visualisation peropératoire des nerfs périprostatiques en temps réel. Prog Urol 2012. [DOI: 10.1016/j.purol.2012.08.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
43
|
Mentine N, Amiel J, Carpentier X, Arnaud P, Durand M, Loeffler J, Marsaud A, Chevallier D. La photovaporisation prostatique avec le laser KTP : une technique prometteuse pour les patients sous traitement antithrombotique. Prog Urol 2012. [DOI: 10.1016/j.purol.2012.08.176] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
44
|
Ahl-Manary S, Jourdan J, Carpentier X, Arnaud P, Mentine N, Durand M, Quintens H, Boukaidi S, Marsaud A, Chevallier D, Amiel J. Bi-transplantation rénale par abord ipsilatéral : expérience d’un centre à propos de 15 patients opérés consécutivement et revue de la littérature. Prog Urol 2012. [DOI: 10.1016/j.purol.2012.08.081] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
45
|
Durand M, Robinson B, Aronowitz E, Fish J, Srivastava A, Sooriakumaran P, Mtui J, Brooks D, Leung R, Gumpeni N, Shih G, Ng A, Tu J, Arnaud P, Bensaid R, Mentine N, Rouscoff Y, Carpentier X, Chevallier D, Amiel J, Tewari A, Ballon D. L’IRM 7 Tesla de la prostate : une imagerie haute définition prometteuse pour assister l’analyse histologique des pièces de prostatectomie radicale. Prog Urol 2012. [DOI: 10.1016/j.purol.2012.08.112] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
46
|
Benko S, Gordon CT, Mallet D, Sreenivasan R, Thauvin-Robinet C, Brendehaug A, Thomas S, Bruland O, David M, Nicolino M, Labalme A, Sanlaville D, Callier P, Malan V, Huet F, Molven A, Dijoud F, Munnich A, Faivre L, Amiel J, Harley V, Houge G, Morel Y, Lyonnet S. Disruption of a long distance regulatory region upstream of SOX9 in isolated disorders of sex development. J Med Genet 2011; 48:825-30. [DOI: 10.1136/jmedgenet-2011-100255] [Citation(s) in RCA: 135] [Impact Index Per Article: 10.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
47
|
Benard J, Saada J, Amiel J, Vignes S, Benachi A, Picone O. Prenatal diagnosis of Milroy disease. Prenat Diagn 2011; 31:1207-9. [DOI: 10.1002/pd.2864] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/10/2011] [Revised: 08/08/2011] [Accepted: 08/08/2011] [Indexed: 11/09/2022]
Affiliation(s)
- J. Benard
- Service de Gynécologie-Obstétrique, Hôpital Antoine Béclère, AP-HP; Université Paris Sud; Clamart France
| | - J. Saada
- Service de Gynécologie-Obstétrique, Hôpital Antoine Béclère, AP-HP; Université Paris Sud; Clamart France
| | - J. Amiel
- Département de Génétique, Hôpital Necker-Enfants Malades, AP-HP, Paris; Université Paris Descartes; France
| | - S. Vignes
- Unité de Lymphologie, Centre national de référence des maladies vasculaires rares, Hôpital Cognacq-Jay; Paris France
| | - A. Benachi
- Service de Gynécologie-Obstétrique, Hôpital Antoine Béclère, AP-HP; Université Paris Sud; Clamart France
| | - O. Picone
- Service de Gynécologie-Obstétrique, Hôpital Antoine Béclère, AP-HP; Université Paris Sud; Clamart France
| |
Collapse
|
48
|
Burlet P, Steichen C, Hesters L, Gigarel N, Kerbrat V, Frydman R, Munnich A, Amiel J, Frydman N, Steffann J. Successful pre-implantation genetic diagnosis for Hirschsprung disease. Clin Genet 2011; 80:403-5. [PMID: 23464651 DOI: 10.1111/j.1399-0004.2011.01634.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
49
|
Lobryeau-Desnus C, Lamy A, Amiel J. [Proposal of a rating scale of posture for simple dysfunctional dysphonia: "S-TRAV"]. Rev Laryngol Otol Rhinol (Bord) 2011; 132:29-40. [PMID: 21977700] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
OBJECTIVE This work aims to create a scale to evaluate posture, quick and easy to perform during the assessment of voice in patients with simple dysfunctional dysphonia. MATERIAL AND METHOD The "S-TRAV" scale was evaluated on 60 subjects with dysphonia and 60 control subjects. It assesses "the overall severity" of the alteration of posture, the "Tension", the "Breathing", the "Ground anchoring" and the "Verticality" both quantitatively (score 0-3) and qualitatively. The patient also assesses his voice disorder and his posture. Postural observation was carried out in five conditions: at rest, conversational voice, reading, projected voice and singing voice. The comparison between the dysphonic subjects and control subjects was used to assess the sensitivity of this tool. Two reviewers rated the scale to determine its reproducibility. RESULTS The scale is sensible for the majority of criteria with a significance coefficient less than 0.05. The most discriminate criteria relate to the cervical spine, the overall score of postural severity assessed by the therapist and verticality. All criteria have a low level of variability between the reviewers under all conditions. Most criteria are correlated with the criterion "Overall Severity" of postural alterations under all conditions. Non-sensible criteria were eliminated from the final scale). CONCLUSION This tool is sensitive, reproducible and relevant in assessing the severity of postural alterations and their location. Further studies will validate the scale on a consistent population.
Collapse
Affiliation(s)
- C Lobryeau-Desnus
- Hôpital Pitié-Salpétrière, Service ORL-Phoniatrie, 47 bd Hôpital, 75013 Paris, France.
| | | | | |
Collapse
|
50
|
Isidor B, Podevin G, Camby C, Mosnier JF, Chauty A, Lyet JM, Fergelot P, Lacombe D, Arveiler B, Pelet A, Amiel J, David A. Rubinstein-Taybi syndrome and Hirschsprung disease in a patient harboring an intragenic deletion of the CREBBP gene. Am J Med Genet A 2010; 152A:1847-8. [PMID: 20583168 DOI: 10.1002/ajmg.a.33480] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Affiliation(s)
- B Isidor
- Service de Génétique Médicale, Nantes University Hospital, Nantes, France.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|